Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-06 · accession 0001683168-21-006141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-07 | 2021-12-06 | CNSP | Downs Christopher | CFO | P - Purchase | $0.94 | +5,000 | 151.5K | +3% | +$4,700 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-06 | P | A | 5,000 | $0.94 | 151,500 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $0.9400 to $0.947299. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |